Avastin (bevacizumab)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
December 2015
ADVERSE REACTIONS
Clinical Trial Experience
Renal Injury
A retrospective analysis across clinical...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts